KRAS and colorectal carcinoma: PNA-clamp technology has been adopted in reactions known as ‘PCR Clamping’ and has been used to identify occult micrometastases in colorectal cancer (CRC) patients [61] and to detect KRAS point mutations in peripheral blood samples of CRC patients [62].